HomeQuestion

Have you noticed increased incidence of skin cancers for solid-organ transplant patients on CTLA4 inhibitors (ie: belatacept)?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How would you manage a patient who developed stage III melanoma while receiving cemiplimab (cycle 10) for locally advanced cutaneous squamous cell carcinoma?

What factors do you weigh most heavily in the selection of radiotherapy versus topical treatments for lentigo maligna in a patient who is not a surgical candidate?

In what circumstances would you recommend adjuvant radiation for a keratocanthoma with SCC after resection?

How do you approach biopsy and management decisions for a rapidly enlarging periocular tumor in an elderly patient with dementia who is unable to communicate and whose family prefers to avoid aggressive treatment?

What clinical criteria do you use to decide when to start oral nicotinamide for chemoprevention?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.